SCHEMBL24252077

SCHEMBL24252077

CCNC(=O)c1cccc(C(C)C)c1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 1/20 0.47
TAS1R1 Q7RTX1 1/20 0.47
TAS1R2 Q8TE23 1/20 0.47
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
GPR139 Q6DWJ6 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 2/20 0.42
BRD4 O60885 1/20 0.42
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HPGD P15428 2/20 0.41
P2RX7 Q99572 1/20 0.41
CXCR2 P25025 1/20 0.39
TSHR P16473 1/20 0.39
HTT P42858 1/20 0.39
CNR2 P34972 1/20 0.39
KCNK3 O14649 1/20 0.39
KCNK9 Q9NPC2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15614407 0.85 KMT2A (0.50) LMNABRD4KMT2AL3MBTL1CXCR2
SCHEMBL13753319 0.84 LMNA (0.52) SMN1; SMN2LMNABRD4KMT2AL3MBTL1
SCHEMBL4158170 0.80 TAS1R3 (0.64) TAS1R3TAS1R1TAS1R2GPR139LMNA
SCHEMBL23894399 0.79 HPGD (0.47) LMNAKMT2AHPGDKCNK3KCNK9
SCHEMBL13841435 0.79 TAS1R3 (0.50) TAS1R3TAS1R1TAS1R2NPC1RAB9A
SCHEMBL22059502 0.78 TAS1R3 (0.45) TAS1R3TAS1R1TAS1R2GPR139LMNA
SCHEMBL11653801 0.78 P2RX7 (0.57) TAS1R3TAS1R1TAS1R2LMNABRD4
SCHEMBL30452200 0.76 TAS1R3 (0.38) TAS1R3TAS1R1TAS1R2NPC1RAB9A
SCHEMBL23879248 0.76 TAS1R3 (0.38) TAS1R3TAS1R1TAS1R2NPC1RAB9A
SCHEMBL18522893 0.76 GABRA1 (0.43) TAS1R3TAS1R1TAS1R2SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220048915-A1 Nitrogen-containing Heterocyclic Compound and Composition Thereof, Preparation Method Therefor, and Application Thereof SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2022-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048915-A1 Nitrogen-containing Heterocyclic Compound and Composition Thereof, Preparation Method Therefor, and Application Thereof MAPK11, WEE1, NOS1 TAS1R3 4830/4885TAS1R1 4456/4885TAS1R2 4763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.